Global Latanoprost Market Size, Share, Trends and Forecast 2022-2030

Description

Market Analysis and Insights: Global Latanoprost Market
Latanoprost drops is a clear colorless liquid and a medication used to treat increased pressure inside the eye. Onset of effects is usually within four hours, and they last for up to a day.

Latanoprost is used to treat high pressure inside the eye due to glaucoma (open angle type) or other eye diseases (e.g., ocular hypertension). It is similar to a natural chemical in the body (prostaglandin) and works by regulating the flow of fluid within the eye which results in lower pressure. Lowering high pressure inside the eye helps to prevent blindness.

In the report, one unit refers to one bottle.

Due to the COVID-19 pandemic, the global Latanoprost market size is estimated to be worth US$ 1406.9 million in 2022 and is forecast to a readjusted size of US$ 1603.1 million by 2028 with a CAGR of 2.2% during the review period. Fully considering the economic change by this health crisis, Brand Drug accounting for % of the Latanoprost global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Open-angle Glaucoma segment is altered to an % CAGR throughout this forecast period.

Pfizer, Mylan and Novartis are the leaders of the Latanoprost industry, which take about 57% market share. North America is the major region of the global market, which takes about 35% market share.

Market Segments

The authors of this research report have explored the key segments: Type and Application. The report offers an in-depth breakdown of type and application segments and their sub-segments. The lucrativeness and growth potential have been looked into by the industry experts in this report. This section of the report also provides sales and revenue forecast data by type and application segments based on sales, price, and revenue for the period 2017-2028. The specialists, to broaden the understanding of the users, have done value chain and raw material analysis in this section.

Segment by Type

Brand Drug

Generic Drug

Segment by Application

Open-angle Glaucoma

Close-angle Glaucoma

Consequence of Covid-19 Pandemic

The authors of this study have enlightened the readers on the rise and effect of the Covid-19 outbreak on the development. They have investigated the changes brought about in the demand/supply side, consumption, supply chain, and sales/manufacturing. The readers will get familiar with the measures that have helped the key players to bring the Latanoprost market back to the pre-covid levels.

Trends & Prospects

In this segment of the report, the specialists have delved into the key growth opportunities that are likely to emerge. This will aid the key players to simplify complex issues related to business and frame future strategies to compete in this competitive environment. This section will certainly assist the players to boldly position their business.

By Region

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

U.A.E

Competitive Outlook

In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and share analysis of the prominent players are also provided in this section. They have also provided reliable sales and revenue data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:

Pfizer

Mylan

Novartis

Apotex

Teva

Taj Pharma

CR Zizhu

TABLE OF CONTENT

1 Study Coverage
1.1 Latanoprost Product Introduction

1.2 Market by Type

1.2.1 Global Latanoprost Market Size Growth Rate by Type, 2017 VS 2021 VS 2028

1.2.2 Brand Drug

1.2.3 Generic Drug

1.3 Market by Application

1.3.1 Global Latanoprost Market Size Growth Rate by Application, 2017 VS 2021 VS 2028

1.3.2 Open-angle Glaucoma

1.3.3 Close-angle Glaucoma

1.4 Study Objectives

1.5 Years Considered

2 Executive Summary

2.1 Global Latanoprost Sales Estimates and Forecasts 2017-2028

2.2 Global Latanoprost Revenue Estimates and Forecasts 2017-2028

2.3 Global Latanoprost Revenue by Region: 2017 VS 2021 VS 2028

2.4 Global Latanoprost Sales by Region

2.4.1 Global Latanoprost Sales by Region (2017-2022)

2.4.2 Global Sales Latanoprost by Region (2023-2028)

2.5 Global Latanoprost Revenue by Region

2.5.1 Global Latanoprost Revenue by Region (2017-2022)

2.5.2 Global Latanoprost Revenue by Region (2023-2028)

2.6 North America

2.7 Europe

2.8 Asia-Pacific

2.9 Latin America

2.10 Middle East & Africa

3 Competition by Manufacturers

3.1 Global Latanoprost Sales by Manufacturers

3.1.1 Global Top Latanoprost Manufacturers by Sales (2017-2022)

3.1.2 Global Latanoprost Sales Market Share by Manufacturers (2017-2022)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Latanoprost in 2021

3.2 Global Latanoprost Revenue by Manufacturers

3.2.1 Global Latanoprost Revenue by Manufacturers (2017-2022)

3.2.2 Global Latanoprost Revenue Market Share by Manufacturers (2017-2022)

3.2.3 Global Top 10 and Top 5 Companies by Latanoprost Revenue in 2021

3.3 Global Latanoprost Sales Price by Manufacturers (2017-2022)

3.4 Analysis of Competitive Landscape

3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Latanoprost Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.4.3 Global Latanoprost Manufacturers Geographical Distribution

3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global Latanoprost Sales by Type

4.1.1 Global Latanoprost Historical Sales by Type (2017-2022)

4.1.2 Global Latanoprost Forecasted Sales by Type (2023-2028)

4.1.3 Global Latanoprost Sales Market Share by Type (2017-2028)

4.2 Global Latanoprost Revenue by Type

4.2.1 Global Latanoprost Historical Revenue by Type (2017-2022)

4.2.2 Global Latanoprost Forecasted Revenue by Type (2023-2028)

4.2.3 Global Latanoprost Revenue Market Share by Type (2017-2028)

4.3 Global Latanoprost Price by Type

4.3.1 Global Latanoprost Price by Type (2017-2022)

4.3.2 Global Latanoprost Price Forecast by Type (2023-2028)

5 Market Size by Application

5.1 Global Latanoprost Sales by Application

5.1.1 Global Latanoprost Historical Sales by Application (2017-2022)

5.1.2 Global Latanoprost Forecasted Sales by Application (2023-2028)

5.1.3 Global Latanoprost Sales Market Share by Application (2017-2028)

5.2 Global Latanoprost Revenue by Application

5.2.1 Global Latanoprost Historical Revenue by Application (2017-2022)

5.2.2 Global Latanoprost Forecasted Revenue by Application (2023-2028)

5.2.3 Global Latanoprost Revenue Market Share by Application (2017-2028)

5.3 Global Latanoprost Price by Application

5.3.1 Global Latanoprost Price by Application (2017-2022)

5.3.2 Global Latanoprost Price Forecast by Application (2023-2028)

6 North America

6.1 North America Latanoprost Market Size by Type

6.1.1 North America Latanoprost Sales by Type (2017-2028)

6.1.2 North America Latanoprost Revenue by Type (2017-2028)

6.2 North America Latanoprost Market Size by Application

6.2.1 North America Latanoprost Sales by Application (2017-2028)

6.2.2 North America Latanoprost Revenue by Application (2017-2028)

6.3 North America Latanoprost Market Size by Country

6.3.1 North America Latanoprost Sales by Country (2017-2028)

6.3.2 North America Latanoprost Revenue by Country (2017-2028)

6.3.3 U.S.

6.3.4 Canada

7 Europe

7.1 Europe Latanoprost Market Size by Type

7.1.1 Europe Latanoprost Sales by Type (2017-2028)

7.1.2 Europe Latanoprost Revenue by Type (2017-2028)

7.2 Europe Latanoprost Market Size by Application

7.2.1 Europe Latanoprost Sales by Application (2017-2028)

7.2.2 Europe Latanoprost Revenue by Application (2017-2028)

7.3 Europe Latanoprost Market Size by Country

7.3.1 Europe Latanoprost Sales by Country (2017-2028)

7.3.2 Europe Latanoprost Revenue by Country (2017-2028)

7.3.3 Germany

7.3.4 France

7.3.5 U.K.

7.3.6 Italy

7.3.7 Russia

8 Asia Pacific

8.1 Asia Pacific Latanoprost Market Size by Type

8.1.1 Asia Pacific Latanoprost Sales by Type (2017-2028)

8.1.2 Asia Pacific Latanoprost Revenue by Type (2017-2028)

8.2 Asia Pacific Latanoprost Market Size by Application

8.2.1 Asia Pacific Latanoprost Sales by Application (2017-2028)

8.2.2 Asia Pacific Latanoprost Revenue by Application (2017-2028)

8.3 Asia Pacific Latanoprost Market Size by Region

8.3.1 Asia Pacific Latanoprost Sales by Region (2017-2028)

8.3.2 Asia Pacific Latanoprost Revenue by Region (2017-2028)

8.3.3 China

8.3.4 Japan

8.3.5 South Korea

8.3.6 India

8.3.7 Australia

8.3.8 Taiwan

8.3.9 Indonesia

8.3.10 Thailand

8.3.11 Malaysia

8.3.12 Philippines

9 Latin America

9.1 Latin America Latanoprost Market Size by Type

9.1.1 Latin America Latanoprost Sales by Type (2017-2028)

9.1.2 Latin America Latanoprost Revenue by Type (2017-2028)

9.2 Latin America Latanoprost Market Size by Application

9.2.1 Latin America Latanoprost Sales by Application (2017-2028)

9.2.2 Latin America Latanoprost Revenue by Application (2017-2028)

9.3 Latin America Latanoprost Market Size by Country

9.3.1 Latin America Latanoprost Sales by Country (2017-2028)

9.3.2 Latin America Latanoprost Revenue by Country (2017-2028)

9.3.3 Mexico

9.3.4 Brazil

9.3.5 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Latanoprost Market Size by Type

10.1.1 Middle East and Africa Latanoprost Sales by Type (2017-2028)

10.1.2 Middle East and Africa Latanoprost Revenue by Type (2017-2028)

10.2 Middle East and Africa Latanoprost Market Size by Application

10.2.1 Middle East and Africa Latanoprost Sales by Application (2017-2028)

10.2.2 Middle East and Africa Latanoprost Revenue by Application (2017-2028)

10.3 Middle East and Africa Latanoprost Market Size by Country

10.3.1 Middle East and Africa Latanoprost Sales by Country (2017-2028)

10.3.2 Middle East and Africa Latanoprost Revenue by Country (2017-2028)

10.3.3 Turkey

10.3.4 Saudi Arabia

11 Company Profiles

11.1 Pfizer

11.1.1 Pfizer Corporation Information

11.1.2 Pfizer Overview

11.1.3 Pfizer Latanoprost Sales, Price, Revenue and Gross Margin (2017-2022)

11.1.4 Pfizer Latanoprost Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 Pfizer Recent Developments

11.2 Mylan

11.2.1 Mylan Corporation Information

11.2.2 Mylan Overview

11.2.3 Mylan Latanoprost Sales, Price, Revenue and Gross Margin (2017-2022)

11.2.4 Mylan Latanoprost Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 Mylan Recent Developments

11.3 Novartis

11.3.1 Novartis Corporation Information

11.3.2 Novartis Overview

11.3.3 Novartis Latanoprost Sales, Price, Revenue and Gross Margin (2017-2022)

11.3.4 Novartis Latanoprost Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 Novartis Recent Developments

11.4 Apotex

11.4.1 Apotex Corporation Information

11.4.2 Apotex Overview

11.4.3 Apotex Latanoprost Sales, Price, Revenue and Gross Margin (2017-2022)

11.4.4 Apotex Latanoprost Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 Apotex Recent Developments

11.5 Teva

11.5.1 Teva Corporation Information

11.5.2 Teva Overview

11.5.3 Teva Latanoprost Sales, Price, Revenue and Gross Margin (2017-2022)

11.5.4 Teva Latanoprost Product Model Numbers, Pictures, Descriptions and Specifications

11.5.5 Teva Recent Developments

11.6 Taj Pharma

11.6.1 Taj Pharma Corporation Information

11.6.2 Taj Pharma Overview

11.6.3 Taj Pharma Latanoprost Sales, Price, Revenue and Gross Margin (2017-2022)

11.6.4 Taj Pharma Latanoprost Product Model Numbers, Pictures, Descriptions and Specifications

11.6.5 Taj Pharma Recent Developments

11.7 CR Zizhu

11.7.1 CR Zizhu Corporation Information

11.7.2 CR Zizhu Overview

11.7.3 CR Zizhu Latanoprost Sales, Price, Revenue and Gross Margin (2017-2022)

11.7.4 CR Zizhu Latanoprost Product Model Numbers, Pictures, Descriptions and Specifications

11.7.5 CR Zizhu Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Latanoprost Industry Chain Analysis

12.2 Latanoprost Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Latanoprost Production Mode & Process

12.4 Latanoprost Sales and Marketing

12.4.1 Latanoprost Sales Channels

12.4.2 Latanoprost Distributors

12.5 Latanoprost Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

13.1 Latanoprost Industry Trends

13.2 Latanoprost Market Drivers

13.3 Latanoprost Market Challenges

13.4 Latanoprost Market Restraints

14 Key Findings in The Global Latanoprost Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

Choose License Type

Checkout Inquiry Sample